Real-Time Surveillance of E-Cigarette, or Vaping, Product-Use Associated Lung Injury (EVALI)
Addictive Behaviors | Tobacco Addiction | COVID-19 Inpatient | COVID-19 Outpatient
What is the purpose of this trial?
The purpose of our research study is to advance our understanding of risk factors for acute illness among people who use vaping or smoking products. Participation in this study will involve surveys, analysis of e-liquids (if used), and analysis of blood and urine. Research staff will collect some information about your demographics, personal history, and lab results to understand more about you and identify risk factors for health problems. Research staff would also like to analyze a sample of any e-liquids recently used. You will receive up to $50 for taking part in this study: $20 for competition of the surveys and an additional $30 if you provide small samples of e-liquids that you recently used.
- Ages18 years and older
- Trial withNational Institute on Drug Abuse/NIH/DHHS
- Start Date02/28/2020
- End Date02/28/2022
- Last Updated07/15/2021
- Study HIC#2000027263